Ganeden Biotech (United States)

Pretreatment characteristics associated with orthodontic treatment duration

Monica A. Fisher, Reid M. Wenger, Mark G. Hans · American Journal of Orthodontics and Dentofacial Orthopedics · 2010 · 124 citations

Pretreatment Characteristics, Outcomes Research, Orthodontic Research +3

Integrate genome-based assessment of safety for probiotic strains: Bacillus coagulans GBI-30, 6086 as a case study

Elisa Salvetti, Luigi Orrù, Vittorio Capozzi et al. · Applied Microbiology and Biotechnology · 2016 · 108 citations

Probiotic, Antimicrobial Resistance Gene, Case Study +7

Opportunities for greener alternatives in chemical formulations

Philip G. Jessop, Faraz Ahmadpour, M. A. Buczynski et al. · Green Chemistry · 2015 · 97 citations · Full text

Engineering, Green Chemistry, Negative Effects +16

Survival and metabolic activity of the GanedenBC³⁰ strain of <i>Bacillus coagulans</i> in a dynamic <i>in vitro</i> model of the stomach and small intestine

Annet Maathuis, David Keller, Sean Farmer · Beneficial Microbes · 2009 · 88 citations · Full text

Bacillus coagulans GBI-30, 6086 Modulates Faecalibacterium prausnitzii in Older Men and Women

Edna P. Nyangale, Sean Farmer, Howard A. Cash et al. · Journal of Nutrition · 2015 · 85 citations · Full text

Dysbiosis, Microbial Disease, Bacteriology +8